Caisse Des Depots ET Consignations trimmed its holdings in shares of Centene Corporation (NYSE:CNC - Free Report) by 44.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,106 shares of the company's stock after selling 20,151 shares during the period. Caisse Des Depots ET Consignations' holdings in Centene were worth $1,033,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Addison Advisors LLC boosted its stake in shares of Centene by 455.6% during the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company's stock worth $26,000 after buying an additional 606 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Centene during the 3rd quarter worth about $27,000. GoalVest Advisory LLC acquired a new position in shares of Centene during the 4th quarter worth about $37,000. Union Bancaire Privee UBP SA bought a new stake in shares of Centene in the 4th quarter valued at about $37,000. Finally, WPG Advisers LLC raised its holdings in shares of Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company's stock valued at $33,000 after purchasing an additional 282 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CNC has been the topic of a number of research analyst reports. The Goldman Sachs Group reaffirmed a "sell" rating and issued a $40.00 target price on shares of Centene in a report on Wednesday. Deutsche Bank Aktiengesellschaft upped their target price on shares of Centene from $39.00 to $53.00 and gave the company a "hold" rating in a report on Wednesday. Wells Fargo & Company upped their target price on shares of Centene from $44.00 to $56.00 and gave the company an "equal weight" rating in a report on Friday. Mizuho upped their target price on shares of Centene from $41.00 to $50.00 and gave the company a "neutral" rating in a report on Wednesday. Finally, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Centene in a report on Monday, April 20th. Six investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $52.12.
Get Our Latest Analysis on Centene
Centene Stock Down 0.6%
Centene stock opened at $53.37 on Friday. The stock has a market cap of $26.36 billion, a P/E ratio of -4.06, a P/E/G ratio of 1.03 and a beta of 1.06. The company has a quick ratio of 1.10, a current ratio of 1.12 and a debt-to-equity ratio of 0.76. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $64.15. The company's 50-day moving average price is $38.91 and its two-hundred day moving average price is $39.45.
Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating the consensus estimate of $2.23 by $1.14. The firm had revenue of $49.94 billion for the quarter, compared to analysts' expectations of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The business's revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.90 EPS. As a group, analysts expect that Centene Corporation will post 3.46 EPS for the current year.
Centene News Roundup
Here are the key news stories impacting Centene this week:
- Positive Sentiment: Q1 results beat expectations: Centene reported stronger-than-expected EPS and raised its outlook, which supports margin improvement narratives that helped multiple brokers upgrade or re-assess the name. Read More.
- Positive Sentiment: Wall Street bullish notes: Truist reiterated a Buy rating and Cantor Fitzgerald upgraded the stock, signaling investor confidence from some major brokers. Read More. Read More.
- Positive Sentiment: Longer-term recovery thesis boosted: A Seeking Alpha piece highlights promising 2027 turnaround prospects and potential momentum reversal—supportive for investors focused on multi‑year recovery. Read More.
- Positive Sentiment: Wells Fargo raised its price target to $56 while keeping an Equal Weight view, indicating some upside in the broker community even as conviction is measured. Read More.
- Neutral Sentiment: Broker PTs raised but ratings cautious: Deutsche Bank, Mizuho and Morgan Stanley all lifted targets (to $53, $50 and $50 respectively) but maintained Hold/Neutral/Equal Weight stances — a modest vote of confidence that stops short of strong endorsement. Read More. Read More. Read More.
- Neutral Sentiment: Analysts’ opinions remain mixed overall — coverage notes a blend of upgrades and cautious takes, keeping sentiment balanced rather than uniformly positive. Read More.
- Negative Sentiment: Lower consensus price target: A brokerage consensus report shows a $42 average target — well below current levels — which could cap upside if that view gains traction. Read More.
- Negative Sentiment: Execution concerns flagged: A Seeking Alpha commentary warns that further upside will require better operational execution, a caution investors may lean on after recent volatility. Read More.
Centene Company Profile
(
Free Report)
Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.